Animal Treatment Market by Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry) & Treatment Type (No Medicalization, Basic Medicalization, Veterinary Care), Country (US, Canada, Germany, UK, France, Spain, Italy, Russia, Austria, Poland, Netherlands, Turkey, Bulgaria, China, India, Japan, Australia, India, South Korea, Thailand, Saudi Arabia) - Global Forecast to 2024
Market Growth Outlook Summary
The global animal healthcare market growth forecasted to transform from ~$40 billion in 2018 to ~$50 billion by 2024, driven by a CAGR of ~6%. The growth of this market can be attributed to increasing government initiatives, which ensure maximum preventive healthcare in animals. A majority of the developed economies have norms that impel owners to have pet insurance.
Companion Animal Population Trends In European Countries
To know about the assumptions considered for the study, Request for Free Sample Report
On the basis of animal type, the animal treatment market is segmented into dogs, cats, pigs, poultry, cattle, and horses. The poultry segment will receive maximum veterinary care in the coming years. Earlier, the health of poultry was neglected to a greater extent. Chickens having underlying conditions were discarded without providing any veterinary treatment. However, with various animal cruelty acts in place, the mortality rate in poultry has decreased.
Based on the type of treatment, the animal treatment market is segmented into no medicalization, basic medicalization, and veterinary care. There has been a considerable decline in the percentage of animals receiving no medicalization, due to the rising awareness regarding the availability of reimbursement for veterinary services. As a result, owners have started prioritizing the health of their companion animals.
The market in Europe is expected to witness significant growth during the forecast period. European countries such as Germany, the UK, and France have shown positive trends in terms of companion animals receiving preventive healthcare. The number of dogs and cats receiving vaccination and treatment in these countries has increased. This trend is projected to continue until the end of 2024. Furthermore, in the case of livestock, animal welfare authorities have assigned diligent veterinarians for farms to assure maximum preventive healthcare.
The leading players in the animal treatment market are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Abaxis (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation (US). These players are pursuing various strategies such as mergers, acquisitions, product launches, and geographical expansions to further increase their shares in the animal treatment market.
Scope of the Animal Treatment Industry:
|
Report Metric |
Details |
|
Market Revenue Size in 2018 |
~$40 billion |
|
Projected Revenue Size by 2024 |
~$50 billion |
|
Industry Growth Rate |
Poised to grow at a CAGR of ~6% |
|
Market Driver |
Forthcoming trends |
|
Market Opportunity |
Emerging economies |
The study categorizes the Animal Treatment Market to forecast revenue and analyze trends in each of the following submarkets:
By Animal Type
- Dogs
- Cats
- Cattle
- Pigs
- Horses
- Poultry
By Treatment
- No Medicalization
- Basic Medicalization
- Veterinary Care
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Switzerland
- Spain
- Russia
- Poland
- Austria
- Netherlands
- Turkey
-
Asia Pacific (APAC)
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Middle East and Africa
- Saudi Arabia
Recent Developments of Animal Treatment Industry
- In June 2016, Abaxis partnered with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
- In June 2016, IDEXX Laboratories launched a Rapid Visual Pregnancy Test for cattle, a point-of-care test that can detect a cow 28 days post-breeding, improving reproductive efficacy, and profitability.
- In January 2017, Neogen launched the Igenity Brangus profiler, a DNA test for the profiling and selection of commercial replacement heifers, in partnership with the International Brangus Breeders Association (IBBA). This launch helped Neogen to diversify and grow its genomic testing portfolio and services.
- In August 2016, Zoetis acquired Scandinavian Micro Biodevices (SMB, Denmark), a manufacturer of point-of-care (POC) solutions for use in veterinary clinics and farms. This acquisition was valued at USD 80 million.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global animal healthcare market?
The global animal healthcare market boasts a total revenue value of ~$50 billion by 2024.
What is the estimated growth rate (CAGR) of the global animal healthcare market?
The global animal healthcare market has an estimated compound annual growth rate (CAGR) of ~6% and a revenue size in the region of ~$40 billion in 2018.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
2 RESEARCH METHODOLOGY
2.1 SECONDARY RESEARCH
2.2 PRIMARY RESEARCH
2.3 ANALYSIS + OUTPUT
3 ANIMAL HEALTHCARE - KEY INSIGHTS
3.1 COMPANION ANIMAL DIAGNOSTICS MARKET
3.2 VETERINARY VACCINES MARKET
3.3 VETERINARY EQUIPMENT AND DISPOSABLES MARKET
3.4 VETERINARY REFERENCE LABORATORIES MARKET
3.5 VETERINARY IMAGING MARKET
4 ANIMAL HEALTHCARE MEDICALIZATION, BY COUNTRY
4.1 EUROPE
4.1.1 UK
4.1.2 GERMANY
4.1.3 FRANCE
4.1.4 RUSSIA
4.1.5 ITALY
4.1.6 SPAIN
4.1.7 AUSTRIA
4.1.8 TURKEY
4.1.9 POLAND
4.1.10 BULGARIA
4.1.11 NETHERLANDS
4.2 ASIA PACIFIC
4.2.1 INDIA
4.2.2 CHINA
4.2.3 JAPAN
4.2.4 SOUTH KOREA
4.2.5 THAILAND
4.2.6 AUSTRALIA
4.3 NORTH AMERICA
4.3.1 US
4.3.2 CANADA
4.4 SAUDI ARABIA
5 APPENDIX
5.1 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
5.2 AUTHOR DETAIL
LIST OF TABLES (67 Tables)
TABLE 1 MARKET DEFINITION
TABLE 2 COUNTRIES COVERED
TABLE 3 EUROPE: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 4 EUROPE: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 5 EUROPE: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 6 UK: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 7 UK: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 8 UK: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 9 GERMANY: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 10 GERMANY: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 11 GERMANY: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 12 FRANCE: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 13 FRANCE: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 14 FRANCE: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 15 RUSSIA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 16 RUSSIA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 17 RUSSIA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 18 ITALY: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 19 ITALY: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 20 ITALY: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 21 SPAIN: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 22 SPAIN: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 23 SPAIN: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 24 AUSTRIA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 25 AUSTRIA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 26 AUSTRIA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 27 TURKEY: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 28 TURKEY: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 29 TURKEY: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 30 POLAND: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 31 POLAND: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 32 POLAND: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 33 BULGARIA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 34 BULGARIA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 35 BULGARIA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 36 NETHERLANDS: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 37 NETHERLANDS: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 38 NETHERLANDS: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 39 INDIA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 40 INDIA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 41 INDIA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 42 CHINA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 43 CHINA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 44 CHINA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 45 JAPAN: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 46 JAPAN: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 47 JAPAN: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 48 SOUTH KOREA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 49 SOUTH KOREA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 50 SOUTH KOREA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 51 THAILAND: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 52 THAILAND: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 53 THAILAND: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 54 AUSTRALIA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 55 AUSTRALIA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 56 AUSTRALIA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 57 US: NUMBER OF VETERINARY VISITS PER HOUSEHOLD, 2018
TABLE 58 US: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 59 US: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 60 US: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 61 CANADA: NUMBER OF VETERINARY PRACTICES IN CANADA, 2017
TABLE 62 CANADA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 63 CANADA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 64 CANADA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
TABLE 65 SAUDI ARABIA: PERCENTAGE OF ANIMALS RECEIVING NO MEDICALIZATION
TABLE 66 SAUDI ARABIA: PERCENTAGE OF ANIMALS RECEIVING BASIC MEDICALIZATION
TABLE 67 SAUDI ARABIA: PERCENTAGE OF ANIMALS UNDER VETERINARY CARE
LIST OF FIGURES (50 Figures)
FIGURE 1 ANIMAL HEALTHCARE - MEDICALIZATION RATE ANALYSIS
FIGURE 2 YEARS CONSIDERED FOR THE STUDY
FIGURE 3 EXPERT INTERVIEWS, BY REGION
FIGURE 4 EXPERT INTERVIEWS, BY SOURCE
FIGURE 5 APPROACH FOLLOWED FOR DETERMINING ANIMAL MEDICALIZATION RATE ANALYSIS
FIGURE 6 GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW
FIGURE 7 GEOGRAPHICAL SNAPSHOT OF THE COMPANION ANIMAL DIAGNOSTICS MARKET
FIGURE 8 COMPETITIVE LEADERSHIP MAPPING
FIGURE 9 MARKET SHARE ANALYSIS
FIGURE 10 GLOBAL VETERINARY VACCINES MARKET OVERVIEW
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY VACCINES MARKET
FIGURE 12 COMPETITIVE LEADERSHIP MAPPING
FIGURE 13 MARKET SHARE ANALYSIS
FIGURE 14 GLOBAL VETERINARY EQUIPMENT AND DISPOSABLES MARKET OVERVIEW
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY EQUIPMENT AND DISPOSABLES MARKET
FIGURE 16 MARKET SHARE ANALYSIS
FIGURE 17 GLOBAL VETERINARY REFERENCE LABORATORIES MARKET OVERVIEW
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY REFERENCE LABORATORIES MARKET
FIGURE 19 COMPETITIVE LEADERSHIP MAPPING
FIGURE 20 MARKET SHARE ANALYSIS
FIGURE 21 VETERINARY IMAGING MARKET OVERVIEW
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY IMAGING MARKET
FIGURE 23 ANIMAL POPULATION IN THE TOP 5 EU COUNTRIES
FIGURE 24 EUROPE: DOG POPULATION
FIGURE 25 EUROPE: CAT POPULATION
FIGURE 26 EUROPE: ANIMAL MEDICAL EXPENDITURE, 2012?2018
FIGURE 27 EUROPE: ANIMAL HEALTHCARE MARKET, BY PRODUCT, 2018
FIGURE 28 PREVENTIVE HEALTHCARE IN THE UK
FIGURE 29 UK: LIFETIME AVERAGE EXPENDITURE ON COMPANION ANIMALS
FIGURE 30 GERMANY: ESTIMATED TRENDS IN CATTLE POPULATION, 2018?2024 (MILLION)
FIGURE 31 RUSSIA: CATTLE POPULATION, 2010?2018 (MILLION)
FIGURE 32 ITALY: COMPANION ANIMAL POPULATION TRENDS
FIGURE 33 SPAIN: COMPANION ANIMAL EXPENDITURE
FIGURE 34 SPAIN: ANTIMICROBIAL CONSUMPTION IN CATTLE
FIGURE 35 AUSTRIA: ANIMAL POPULATION, 2018 (MILLION)
FIGURE 36 TURKEY: ESTIMATED TRENDS IN CATTLE POPULATION, 2018?2024 (MILLION)
FIGURE 37 POLAND: POULTRY POPULATION TRENDS
FIGURE 38 BULGARIA: MEAT PRODUCTION, 2017
FIGURE 39 BULGARIA: CATTLE POPULATION TRENDS, 2018?2024 (MILLION)
FIGURE 40 NETHERLANDS: CATTLE POPULATION, 2010?2016 (MILLION)
FIGURE 41 NETHERLANDS: CATTLE POPULATION FORECAST, 2017?2024 (MILLION)
FIGURE 42 INDIA: CONTRIBUTION FROM ANIMAL HEALTH PRODUCTS, 2018
FIGURE 43 CHINA: ESTIMATED PIG POPULATION, 2017?2024 (MILLION)
FIGURE 44 JAPAN: REGULATORY FRAMEWORK
FIGURE 45 SOUTH KOREA: ESTIMATED CATTLE POPULATION, 2017?2024 (MILLION)
FIGURE 46 THAILAND: ESTIMATED PIG POPULATION, 2017?2024 (MILLION)
FIGURE 47 AUSTRALIA: ESTIMATED CATTLE POPULATION TRENDS, 2017?2024 (MILLION)
FIGURE 48 AUSTRALIA: TOTAL PET POPULATION, 2019
FIGURE 49 SAUDI ARABIA: TRENDS IN CATTLE IMPORTS, 2007?2015 (MILLION)
FIGURE 50 SAUDI ARABIA: ESTIMATED TRENDS IN CATTLE IMPORTS, 2016?2024 (MILLION)
This study involved the extensive use of both primary and secondary sources. The research process included a study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the animal treatment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, presidents, vice presidents, marketing managers, product managers, sales executives, business development executives, and technology and innovation directors of companies providing veterinary care products. A breakdown of primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Analysis
A robust methodology was utilized while analyzing the animal treatment rate, wherein data was gathered through secondary sources and was further validated through primary interviews. Animal population data, disease prevalence data, and diagnosis trends were studied through government publications and articles released from associations such as OIE. Further, the diagnosis rate and disease prevalence rate in animals was verified by conducting several primary interviews.
Data Triangulation
To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To analyze the medicalization rate in dogs, cats, horses, pigs, cattle, and poultry
- To provide detailed information about the key factors influencing animal treatment rate (such as country-wise regulatory scenario, animal welfare initiatives, and market entry barriers)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall animal treatment market
- To analyze market opportunities for stakeholders and provide details of the animal healthcare scenario for various countries
Generating Response ...
Growth opportunities and latent adjacency in Animal Treatment Market